Insider · CIK 0001580787
Pratik Shah
Files at SPRY (ARS Pharmaceuticals, Inc.), DSGN (Design Therapeutics, Inc.). First filing -, latest -.
Pratik Shah files SEC Form 4 as CEO, president, chair and director at SPRY (ARS Pharmaceuticals, Inc.), and also at DSGN (Design Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Pratik Shah has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | SPRY ARS Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 26, 2026 |
| Jan 2, 2026 | DSGN Design Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +750,000 | $0.00 | $0 | 750,000 | Jan 5, 2026 |
| Dec 9, 2025 | DSGN Design Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +525,000 | $0.00 | $0 | 525,000 | Dec 11, 2025 |
| Dec 9, 2025 | DSGN Design Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +525,000 | $0.00 | $0 | 525,000 | Dec 11, 2025 |
| Nov 12, 2025 | SPRY ARS Pharmaceuticals, Inc. | GGift Common Stockindirect: By The Pratik Shah Living Trust dated June 15, 2011 | -250,000 | $0.00 | $0 | 4,574,554 | Nov 14, 2025 |
| Nov 12, 2025 | SPRY ARS Pharmaceuticals, Inc. | GGift Common Stockindirect: By The Pratik Shah Living Trust dated June 15, 2011 | -100,000 | $0.00 | $0 | 4,474,554 | Nov 14, 2025 |
| Jun 25, 2025 | SPRY ARS Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 27, 2025 |
| Jan 2, 2025 | DSGN Design Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Jan 6, 2025 |
Questions about Pratik Shah
Answered from the filings on this page, as of the latest one.
Is Pratik Shah buying or selling?
Pratik Shah has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Pratik Shah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pratik Shah has 0.
Where does Pratik Shah file Form 4?
Pratik Shah has filed Form 4 at SPRY (ARS Pharmaceuticals, Inc.); DSGN (Design Therapeutics, Inc.) as President, CEO and Chairperson. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.